关于公布2025年上半年安徽省中药饮片生产企业自主停产情况的通告〔2025〕年第21号

Core Viewpoint - The Anhui Provincial Drug Supervision Administration has organized a review of the self-suspension status of traditional Chinese medicine (TCM) decoction piece manufacturers in the province to enhance supervision and ensure the quality and safety of TCM production [2]. Group 1: Self-Suspension of TCM Manufacturers - A total of 29 TCM manufacturers in Anhui Province have reported self-suspension of production activities during the first half of 2025 [2][3]. - The reasons for self-suspension include proactive reporting by companies and findings during supervisory inspections [2]. - The self-suspension dates range from December 23, 2022, to July 7, 2025, indicating ongoing compliance and regulatory oversight [2][3]. Group 2: Types of Products Affected - The suspended products include various types of TCM decoction pieces, with some companies specifically mentioning toxic decoction pieces [2][3]. - The production processes affected include net processing, cutting, steaming, boiling, frying, and other methods, highlighting the diverse nature of TCM manufacturing [2][3]. - Companies such as Anhui Tianhe Medicinal Materials Development Co., Ltd. and Anhui Borun Pharmaceutical Co., Ltd. are among those that have reported self-suspension for different reasons [2][3].